Fermenta Biotech [FERMENTA] vs Gujarat Themis [GUJTHEM] Detailed Stock Comparison
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Fermenta Biotech Ltd. wins in 11 metrics, Gujarat Themis Biosyn Ltd. wins in 9 metrics, with 0 ties. Fermenta Biotech Ltd. appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Fermenta Biotech Ltd. | Gujarat Themis Biosyn Ltd. | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 10.85 | 73.73 | Fermenta Biotech Ltd. |
| Price-to-Book Ratio | 2.40 | 13.36 | Fermenta Biotech Ltd. |
| Debt-to-Equity Ratio | 29.03 | 27.04 | Gujarat Themis Biosyn Ltd. |
| PEG Ratio | -0.17 | -17.55 | Fermenta Biotech Ltd. |
| EV/EBITDA | 8.13 | 52.76 | Fermenta Biotech Ltd. |
| Profit Margin (TTM) | 16.00% | 29.99% | Gujarat Themis Biosyn Ltd. |
| Operating Margin (TTM) | 14.26% | 40.16% | Gujarat Themis Biosyn Ltd. |
| EBITDA Margin (TTM) | 14.26% | 40.16% | Gujarat Themis Biosyn Ltd. |
| Return on Equity | 21.44% | 19.64% | Fermenta Biotech Ltd. |
| Return on Assets (TTM) | 12.51% | 16.19% | Gujarat Themis Biosyn Ltd. |
| Free Cash Flow (TTM) | $187.69M | $-251.22M | Fermenta Biotech Ltd. |
| Dividend Yield | 0.71% | 0.17% | Fermenta Biotech Ltd. |
| 1-Year Return | -5.37% | 31.69% | Gujarat Themis Biosyn Ltd. |
| Price-to-Sales Ratio (TTM) | 1.71 | 22.23 | Fermenta Biotech Ltd. |
| Enterprise Value | $9.90B | $36.09B | Gujarat Themis Biosyn Ltd. |
| EV/Revenue Ratio | 1.82 | 22.65 | Fermenta Biotech Ltd. |
| Gross Profit Margin (TTM) | 62.42% | 83.29% | Gujarat Themis Biosyn Ltd. |
| Revenue per Share (TTM) | $186 | $15 | Fermenta Biotech Ltd. |
| Earnings per Share (Diluted) | $29.63 | $4.40 | Fermenta Biotech Ltd. |
| Beta (Stock Volatility) | -0.13 | -0.17 | Gujarat Themis Biosyn Ltd. |
Fermenta Biotech Ltd. vs Gujarat Themis Biosyn Ltd. Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Fermenta Biotech Ltd. | 0.80% | 8.12% | 5.90% | 0.46% | 17.65% | -9.36% |
| Gujarat Themis Biosyn Ltd. | 2.45% | -7.03% | 7.92% | 39.85% | 0.71% | -8.80% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Fermenta Biotech Ltd. | -5.37% | 110.03% | -8.87% | 55.86% | 55.86% | 55.86% |
| Gujarat Themis Biosyn Ltd. | 31.69% | 84.69% | 84.69% | 84.69% | 84.69% | 84.69% |
Performance & Financial Health Analysis: Fermenta Biotech Ltd. vs Gujarat Themis Biosyn Ltd.
| Metric | FERMENTA | GUJTHEM |
|---|---|---|
| Market Information | ||
| Market Cap | ₹9.28B | ₹35.41B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 14,040 | 79,452 |
| 90 Day Avg. Volume | 18,796 | 106,446 |
| Last Close | ₹319.55 | ₹411.65 |
| 52 Week Range | ₹256.40 - ₹399.00 | ₹225.05 - ₹479.00 |
| % from 52W High | -19.91% | -14.06% |
| All-Time High | ₹449.00 (Feb 10, 2025) | ₹479.00 (Oct 27, 2025) |
| % from All-Time High | -28.83% | -14.06% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -0.12% | 0.10% |
| Quarterly Earnings Growth | -0.66% | -0.04% |
| Financial Health | ||
| Profit Margin (TTM) | 0.16% | 0.30% |
| Operating Margin (TTM) | 0.14% | 0.40% |
| Return on Equity (TTM) | 0.21% | 0.20% |
| Debt to Equity (MRQ) | 29.03 | 27.04 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹134.13 | ₹24.29 |
| Cash per Share (MRQ) | ₹17.83 | ₹0.92 |
| Operating Cash Flow (TTM) | ₹-59,490,000 | ₹970.68M |
| Levered Free Cash Flow (TTM) | ₹768.62M | ₹487.72M |
| Dividends | ||
| Last 12-Month Dividend Yield | 0.71% | 0.17% |
| Last 12-Month Dividend | ₹2.50 | ₹0.67 |
Valuation & Enterprise Metrics Analysis: Fermenta Biotech Ltd. vs Gujarat Themis Biosyn Ltd.
| Metric | FERMENTA (Apr 24, 2026) | GUJTHEM (Apr 24, 2026) |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 10.85 | 73.73 |
| Forward P/E | N/A | N/A |
| PEG Ratio | -0.17 | -17.55 |
| Price to Sales (TTM) | 1.71 | 22.23 |
| Price to Book (MRQ) | 2.40 | 13.36 |
| Market Capitalization | ||
| Market Capitalization | ₹9.28B | ₹35.41B |
| Enterprise Value | ₹9.90B | ₹36.09B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 1.82 | 22.65 |
| Enterprise to EBITDA | 8.13 | 52.76 |
| Risk & Other Metrics | ||
| Beta | -0.13 | -0.17 |
| Book Value per Share (MRQ) | ₹134.13 | ₹24.29 |
Financial Statements Comparison: Fermenta Biotech Ltd. vs Gujarat Themis Biosyn Ltd.
Financial Metrics
Loading Financial Charts...
Revenue
Operating Margin
Profit Margin
Long Term Debt
Income Flow Analysis
Financial Statements Comparison
Income Statement
| Metric | FERMENTA (2025) | GUJTHEM (2025) |
|---|---|---|
| Revenue/Sales | 4.67B | 1.51B |
| Cost of Goods Sold | 1.63B | 318.78M |
| COGS % of Revenue | 35.0% | 21.1% |
| Gross Profit | 3.04B | 1.19B |
| Gross Margin | 65.0% | 78.9% |
| Research & Development | N/A | 34.37M |
| Operating Income (EBIT) | 933.53M | 642.49M |
| Operating Margin | 20.0% | 42.6% |
| EBITDA | 1.24B | 713.04M |
| EBITDA Margin | 26.6% | 47.3% |
| Pre-Tax Income | 832.08M | 655.38M |
| Pre-Tax Income % of Revenue | 17.8% | 43.5% |
| Income Tax | 68.05M | 167.66M |
| Income Tax % of Revenue | 1.5% | 11.1% |
| Net Income (Profit) | 764.03M | 487.72M |
| Profit Margin | 16.4% | 32.3% |
Balance Sheet & Liquidity Metrics
| Metric | FERMENTA (2025) | GUJTHEM (2025) |
|---|---|---|
| Cash & Equivalents | 282.40M | 116.94M |
| Total Current Assets | 3.35B | 519.73M |
| Total Current Assets % of Revenue | 71.8% | 34.5% |
| Total Current Liabilities | 2.12B | 205.60M |
| Total Current Liabilities % of Revenue | 45.4% | 13.6% |
| Long-Term Debt | 194.91M | 296.36M |
| Long-Term Debt % of Revenue | 4.2% | 19.7% |
| Total Shareholders Equity | 3.59B | 2.48B |
| Retained Earnings | 3.25B | 2.37B |
| Retained Earnings % of Revenue | 69.7% | 157.4% |
| Property, Plant & Equipment | 2.16B | 411.30M |
Cash Flow Statement Comparison
| Metric | FERMENTA (2025) | GUJTHEM (2025) |
|---|---|---|
| Operating Cash Flow | -59.49M | 970.68M |
| Operating Cash Flow % of Revenue | -1.3% | 64.4% |
| Capital Expenditures | -28.82M | -1.16B |
| Free Cash Flow | 187.69M | -251.22M |
| FCF Margin | 4.0% | -16.7% |
| Debt Repayment | -358.24M | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | FERMENTA | GUJTHEM |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Shares Outstanding | 28.87M | 108.97M |
| Float Shares | 8.42M | 29.52M |
| % Held by Insiders | 71.66% | 71.98% |
| % Held by Institutions | 0.00% | 1.18% |
| % Held by Public | 28.34% | 26.84% |
Dividend Analysis & Yield Comparison: Fermenta Biotech Ltd. vs Gujarat Themis Biosyn Ltd.
| Metric | FERMENTA | GUJTHEM |
|---|---|---|
| Last 12-Month Dividend | ₹2.50 | ₹0.67 |
| Last 12-Month Dividend Yield | 0.71% | 0.17% |
| 3-Year Avg Annual Dividend | ₹0.83 | ₹0.22 |
| 3-Year Avg Dividend Yield | 0.71% | 0.17% |
| 3-Year Total Dividends | ₹2.50 | ₹0.67 |
| Ex-Dividend Date | Aug 06, 2025 | Sep 04, 2025 |